|
1. |
The HIPAA Privacy Rule and its Impact on Pediatric Research |
|
Journal of Pediatric Gastroenterology and Nutrition,
Volume 37,
Issue 5,
2003,
Page 527-527
Preview
|
PDF (63KB)
|
|
ISSN:0277-2116
出版商:OVID
年代:2003
数据来源: OVID
|
2. |
Protein-Losing Enteropathy in Patients with Fontan Operations |
|
Journal of Pediatric Gastroenterology and Nutrition,
Volume 37,
Issue 5,
2003,
Page 528-530
Brigitte,
Preview
|
PDF (147KB)
|
|
ISSN:0277-2116
出版商:OVID
年代:2003
数据来源: OVID
|
3. |
Feeble Cholangiocytes, Toxic Bile, and Nonsyndromic Paucity of Interlobular Bile Ducts |
|
Journal of Pediatric Gastroenterology and Nutrition,
Volume 37,
Issue 5,
2003,
Page 531-532
A.,
Preview
|
PDF (110KB)
|
|
ISSN:0277-2116
出版商:OVID
年代:2003
数据来源: OVID
|
4. |
Glutamine Supplements in Premature Infants: Why and How |
|
Journal of Pediatric Gastroenterology and Nutrition,
Volume 37,
Issue 5,
2003,
Page 533-535
Josef,
Preview
|
PDF (150KB)
|
|
ISSN:0277-2116
出版商:OVID
年代:2003
数据来源: OVID
|
5. |
Is Eicosapentaenoic Acid Useful in the Treatment of Ulcerative Colitis in Children? |
|
Journal of Pediatric Gastroenterology and Nutrition,
Volume 37,
Issue 5,
2003,
Page 536-537
Ángel,
Preview
|
PDF (104KB)
|
|
ISSN:0277-2116
出版商:OVID
年代:2003
数据来源: OVID
|
6. |
Variceal Bleeding in Children |
|
Journal of Pediatric Gastroenterology and Nutrition,
Volume 37,
Issue 5,
2003,
Page 538-545
Jean,
Preview
|
PDF (364KB)
|
|
ISSN:0277-2116
出版商:OVID
年代:2003
数据来源: OVID
|
7. |
Nonsyndromic Paucity of Interlobular Bile Ducts: Report of 10 Patients |
|
Journal of Pediatric Gastroenterology and Nutrition,
Volume 37,
Issue 5,
2003,
Page 546-549
Vered,
Yehezkely-Schildkraut Mariana,
Munichor Hanna,
Mandel Drora,
Berkowitz Corina,
Hartman Orly,
Eshach-Adiv Raanan,
Preview
|
PDF (201KB)
|
|
摘要:
ObjectivesOnly a few reports of nonsyndromic paucity of interlobular bile ducts (NS-PILBD) have been published. The authors' aim was to outline the clinical and laboratory profile of patients with NS-PILBD diagnosed at a tertiary referral center.MethodsThe authors reviewed all the reports of pediatric liver biopsies performed between 1991 and 2000 at their institution. Upon diagnosis of NS-PILBD, patients' records were examined for clinical, laboratory, and histologic data, and liver biopsy specimens were re-evaluated.ResultsThree hundred biopsies were performed in children during the study period, of which 64 were in infants younger than 1 year. NS-PILBD was diagnosed in 10 of 64 (16%) biopsy specimens. Mean age at presentation was 10 days (range, 1 day–6 weeks), and mean follow-up was 4.5 years (range, 1–9 years). An underlying condition was identified in 70% of children with NS-PILBD: namely congenital cytomegalovirus (n = 2), progressive familial intrahepatic cholestasis (PFIC, n = 2), mitochondrial DNA depletion (n = 1), Niemann-Pick type C (n = 1), and arthrogryposis multiplex congenita, renal dysfunction, and cholestasis (ARC syndrome; n = 1). All children presented with jaundice. Four children had initially acholic stools. At their last follow-up visit, failure to thrive was present in five children, and cholestasis in six children. Mortality was noted only in children with metabolic diseases (n = 2).ConclusionsIn the study, NS-PILBD was common in young children undergoing liver biopsy. Although NS-PILBD is nonspecific, a wide survey for inborn errors of metabolism should be included in the diagnostic work-up of NS-PILBD. In the authors' center, the association of certain metabolic diseases with NS-PILBD carries a grave prognosis.
ISSN:0277-2116
出版商:OVID
年代:2003
数据来源: OVID
|
8. |
A Randomized, Controlled Trial of Parenteral Glutamine in Ill, Very Low Birth-weight Neonates |
|
Journal of Pediatric Gastroenterology and Nutrition,
Volume 37,
Issue 5,
2003,
Page 550-553
S.,
Thompson B.,
McClure T.,
Preview
|
PDF (235KB)
|
|
摘要:
ObjectiveThe role of “novel substrates” in neonatal nutrition has generated much interest in recent years. Glutamine has been recognized as a “conditionally essential” amino acid in critically ill adults, particularly for gut and immune function; however, its potential role in the neonate remains unclear. The authors examined the safety and benefits of parenteral glutamine in ill, preterm neonates.DesignRandomized controlled trial.MethodsThirty-five ill preterm neonates of <1000 g birth-weight were randomized to receive either glutamine-supplemented parenteral nutrition (PN) (n = 17) or standard PN (n = 18).ResultsThere were no significant differences in birth-weight, gestational age, male-to-female ratio, or Clinical Risk Index for Babies (CRIB) score between the two groups. During PN there were no significant differences between the groups in white cell count, differential white cell count, blood urea nitrogen, plasma ammonia, lactate, pyruvate, plasma glutamine, or glutamate. The median time to achieving full enteral nutrition (FEN) was shorter in the study group (13 days vs. 21 days,P< 0.05). The number of episodes of culture-positive sepsis or age at discharge did not differ between groups.ConclusionsParenteral glutamine appears to be well tolerated and safe in the ill, preterm neonate. It may reduce the time to achieving FEN.
ISSN:0277-2116
出版商:OVID
年代:2003
数据来源: OVID
|
9. |
Establishing Enteral Feeding in Preterm Infants with Feeding Intolerance: A Randomized Controlled Study of Low-dose Erythromycin |
|
Journal of Pediatric Gastroenterology and Nutrition,
Volume 37,
Issue 5,
2003,
Page 554-558
Steven,
Ng Joseph Manuel,
Gomez Victor Samuel,
Rajadurai Seang-Mei,
Saw Seng-Hock,
Preview
|
PDF (251KB)
|
|
摘要:
ObjectiveA prospective, double-blind, randomized, controlled trial was conducted to evaluate the effect of low-dose erythromycin on the time taken to attain full enteral feedings in preterm infants with very low birth weight and feeding intolerance.MethodsTwo groups of preterm infants (birth weight ≤ 1500 g) with feeding intolerance were randomized to either low-dose erythromycin (5 mg/kg every 8 hours) or 5% dextrose placebo, both of which were discontinued 1 week after full enteral feedings were tolerated. The primary outcome variable was the time taken to attain full enteral feedings of at least 130 mL/kg/d.ResultsThe gestational age at birth was similar in the two groups (erythromycin, 27.1 ± 1.9 weeks; placebo, 27.5 ± 2.9 weeks). The mean birth weight of the erythromycin group was lower (806.3 ± 215.6 g) than the placebo group (981.4 ± 285.4 g;P= 0.18), and included more infants who were small for gestational age (4/13 = 31% versus 1/11 = 9%;P= 0.224). There was no difference between the two groups with regard to the volume of feedings they were receiving at the time of enrollment. Reduction in symptoms of gastroesophageal reflux was similar in the two groups. 3 of 13 in the erythromycin group and 4 of 11 in the placebo group improved during the study (P= 0.565). The mean time to attain full enteral feedings after enrollment was 24.9 + 2.9 days in the erythromycin group and 30.8 ± 4.1 days in the placebo group, a difference that did not reach statistical significance (P= 0.17).ConclusionsLow-dose erythromycin did not reduce the time taken to attain full enteral feedings in preterm infants with very low birth weight and feeding intolerance. Gastroesophageal reflux decreased as a consequence of maturation of the gastrointestinal tract and not because of erythromycin. These preliminary results justify verification in larger multicenter trials.
ISSN:0277-2116
出版商:OVID
年代:2003
数据来源: OVID
|
10. |
Does Breast Feeding Influence Liver Biochemistry? |
|
Journal of Pediatric Gastroenterology and Nutrition,
Volume 37,
Issue 5,
2003,
Page 559-565
Marianne,
Jørgensen Peter,
Ott Anders,
Juul Niels,
Skakkebæk Kim,
Preview
|
PDF (369KB)
|
|
摘要:
ObjectiveIt is assumed that early feeding can affect liver biochemistry because breast-fed infants have a higher risk of hyperbilirubinemia than formula-fed infants. The authors sought to determine how feeding mode affected liver biochemistry in healthy term infants.MethodsHealthy term infants were followed up during infancy with a monthly questionnaire about feeding mode. Blood samples were obtained at 2, 6, and 9 months. Liver biochemistry (serum albumin, alkaline phosphatase, lactic dehydrogenase, aspartate aminotransferase [AST], and bilirubin), total insulin-like growth factor 1 (IGF-I), and insulin growth factor binding protein 3 (IGFBP-3) were determined at all ages.ResultsMean AST and bilirubin were significantly higher in breast-fed infants at 2 and 6 months. In addition, mean albumin levels were higher in breast-fed infants at 2 months. Alkaline phosphatase, IGF-I, IGFBP-3, and lactic dehydrogenase levels did not differ between the feeding groups. AST levels did not correlate significantly with bilirubin, albumin, alkaline phosphatase, or lactic dehydrogenase values. There was a strong positive association between AST and IGF-I at 2 months (r = 0.47,P= 0.004).ConclusionCytomegalovirus infection, vitamin K deficiency, and macromolecular forms of AST could be an explanation for a higher AST level among breast-fed infants. However, no other clinical or paraclinical sign of liver disease was seen, all infants were given oral vitamin K, and the AST did not rise to levels comparable to those seen in individuals with macromolecular AST. The authors speculate the most likely explanation of the elevated AST is induction of hepatocytes by factors in human milk. This is supported by the higher albumin levels in breast-fed infants and the positive association between AST and IGF-I.
ISSN:0277-2116
出版商:OVID
年代:2003
数据来源: OVID
|
|